Randomised Phase 2 Study Of Nivolumab (N) Versus Nivolumab And Ipilimumab (Ni) Combination In Egfr Mutant Nsclc
JOURNAL OF THORACIC ONCOLOGY(2021)
关键词
EGFR mutation, non-small cell lung cancer, Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要